Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-03-01 @ 6:28 AM
Study NCT ID:
NCT02875366
Status:
COMPLETED
Last Update Posted:
2019-06-17
First Post:
2016-08-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effects of Lumacaftor/Ivacaftor (LUM/IVA) on Exercise Tolerance in Subjects With Cystic Fibrosis (CF), Homozygous for the F508del-CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cystic Fibrosis | View |
Keywords: